Charles Moore, MD
Family Medicine · Saint Louis, MONPI 1902877012
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Kerecis Limited at 24.9% of the total. 2025 is the largest year on record at $759, 5.5 times the $138 reported in 2022.
Across 35 payments — averaging $41.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$363
- Smith+Nephew$288
- Organogenesis Inc.$264
- ETS Wound Care LLC$258
- Reprise Biomedical, Inc.$141
- Hydrofera LLC$71
- plus $70 from 4 others
What the payments were for
- Food & beverage$1,454100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 9 | $363 |
| Smith+Nephew | 6 | $288 |
| Organogenesis Inc. | 4 | $264 |
| ETS Wound Care LLC | 8 | $258 |
| Reprise Biomedical, Inc. | 1 | $141 |
| Hydrofera LLC | 3 | $71 |
| Mimedx Group, Inc. | 1 | $20 |
| Solventum Corporation | 1 | $17 |
| Convatec Inc. | 1 | $17 |
| Integra Lifesciences Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$1,097
- Kerecis GraftGuide$274
- GRAFIX PL$226
- STRAVIX PL$226
- MIRO3D$141
- PuraPly$121
- Grafix XC$118
- Stravix$118
- NuShield$105
How this compares
$1,454 in reported general payments places this provider in the 70th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clindamycin Phosphate | 13 | $1,758 |
| Clindamycin Hcl | 17 | $265 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $185 |
| Methylprednisolone | 19 | $160 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 13 | $138 |
| Doxycycline Hyclate | 15 | $102 |
| Amoxicillin | 39 | $87 |
| Azithromycin | 31 | $70 |
| Cephalexin | 11 | $56 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Saint Louis
- Michael DonovanSaint Louis$78K
- Jarad SchwartzSaint Louis$36K
- Christina RobinsSaint Louis$27K
- Michael SpeziaSaint Louis$26K
- David GlickSaint Louis$17K
- Aaron BjornSaint Louis$16K
- Paul RutledgeSaint Louis$16K
- Melissa MurraySaint Louis$15K
- Robert PozziSaint Louis$15K
- Amy MillerSaint Louis$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.